Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.
- DOI
- 10.1002/cam4.72145
- Published
- 2026 Aug
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.72145,
title = {Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.},
author = {Sakai T and Kawasaki Y and Sakamoto I and Hishinuma E and Matsukawa N and Chiba D and Sato T and Morozumi K and Maekawa M and Mano N and Ito A},
year = {2026},
journal = {Cancer medicine},
doi = {10.1002/cam4.72145},
url = {https://doi.org/10.1002/cam4.72145}
}RIS
TY - JOUR TI - Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification. AU - Sakai T AU - Kawasaki Y AU - Sakamoto I AU - Hishinuma E AU - Matsukawa N AU - Chiba D AU - Sato T AU - Morozumi K AU - Maekawa M AU - Mano N AU - Ito A PY - 2026 JO - Cancer medicine DO - 10.1002/cam4.72145 UR - https://doi.org/10.1002/cam4.72145 ER -
APA
T, S., Y, K., I, S., E, H., N, M., D, C., T, S., K, M., M, M., N, M., & A, I. (2026). Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.. Cancer medicine. https://doi.org/10.1002/cam4.72145
Source records
- pubmed · retrieved 2026-09-25T04:44:46.975Z